BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

9 articles for U Reilly

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Heterocyclic methylsulfone hydroxamic acid LpxC inhibitors as Gram-negative antibacterial agents.EBI
Pfizer
Potent inhibitors of LpxC for the treatment of Gram-negative infections.EBI
Pfizer
Late-Stage Lead Diversification Coupled with Quantitative Nuclear Magnetic Resonance Spectroscopy to Identify New Structure-Activity Relationship Vectors at Nanomole-Scale Synthesis: Application to Loratadine, a Human Histamine HEBI
Pfizer
Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV.EBI
Pfizer
Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious gram-negative infections.EBI
Pfizer
Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV.EBI
Pfizer
SULFONE- AND SULFOXIMINE-BASED SELECTIVE PARP1 INHIBITORSBDB
Enliven
NOVEL COMPOUNDS COMPRISING A NEW CLASS OF TRANSTHYRETIN LIGANDS FOR TREATMENT OF COMMON AGE-RELATED COMORBIDITIESBDB
Columbia University
Analyzing airway inflammation with chemical biology: dissection of acidic mammalian chitinase function with a selective drug-like inhibitor.BDB
University of Edinburgh